COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AbbVie Inc. | COM | 00287Y109 | 904,636 | 14,343,358 | SH | | SOLE | | 14,343,358 | 0 | 0 |
Abeona Therapeutics Inc. | COM | 00289Y107 | 610 | 101,680 | SH | | SOLE | | 101,680 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 821,327 | 25,819,768 | SH | | SOLE | | 25,819,768 | 0 | 0 |
Acceleron Pharma Inc. | COM | 00434H108 | 1,041 | 28,765 | SH | | SOLE | | 28,765 | 0 | 0 |
Achaogen, Inc. | COM | 004449104 | 479 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Achillion Pharmaceuticals, Inc. | COM | 00448Q201 | 20,052 | 2,475,515 | SH | | SOLE | | 2,475,515 | 0 | 0 |
Acorda Therapeutics, Inc. | COM | 00484M106 | 76,443 | 3,661,082 | SH | | SOLE | | 3,661,082 | 0 | 0 |
Adamas Pharmaceuticals, Inc. | COM | 00548A106 | 2,833 | 172,630 | SH | | SOLE | | 172,630 | 0 | 0 |
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 705 | 100,000 | SH | | SOLE | | 600,000 | 0 | 0 |
Advanced Accelerator Applications S.A. | SPONSORED ADR | 00790T100 | 39,194 | 1,029,247 | SH | | SOLE | | 2,058,494 | 0 | 0 |
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 2,591 | 404,230 | SH | | SOLE | | 404,230 | 0 | 0 |
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 11,298 | 299,356 | SH | | SOLE | | 299,356 | 0 | 0 |
Affimed N.V. | COM | N01045108 | 1,112 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Agios Pharmaceuticals, Inc. | COM | 00847X104 | 10,982 | 207,915 | SH | | SOLE | | 207,915 | 0 | 0 |
Aimmune Therapeutics, Inc. | COM | 00900T107 | 10,109 | 673,908 | SH | | SOLE | | 673,908 | 0 | 0 |
Akari Therapeutics plc | SPONSORED ADR | 00972G108 | 4,229 | 496,901 | SH | | SOLE | | 49,690,100 | 0 | 0 |
Alcobra Ltd. | SHS | M2239P109 | 5,771 | 2,336,359 | SH | | SOLE | | 2,336,359 | 0 | 0 |
Alder BioPharmaceuticals, Inc. | COM | 014339105 | 7,122 | 217,328 | SH | | SOLE | | 217,328 | 0 | 0 |
Aldeyra Therapeutics, Inc. | COM | 01438T106 | 1,110 | 142,000 | SH | | SOLE | | 142,000 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 801,815 | 6,543,295 | SH | | SOLE | | 6,543,295 | 0 | 0 |
Alkermes plc | SHS | G01767105 | 11,769 | 250,251 | SH | | SOLE | | 250,251 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | COM | 02043Q107 | 769 | 11,340 | SH | | SOLE | | 11,340 | 0 | 0 |
Amarin Corporation plc | SPONSORED ADR NEW | 023111206 | 65,811 | 20,630,477 | SH | | SOLE | | 20,630,477 | 0 | 0 |
Aptose Biosciences Inc. | COM NEW | 03835T200 | 909 | 404,211 | SH | | SOLE | | 404,211 | 0 | 0 |
Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | 140,762 | 10,536,092 | SH | | SOLE | | 10,536,092 | 0 | 0 |
Arbutus Biopharma Corporation | COM | 03879J100 | 621 | 180,582 | SH | | SOLE | | 180,582 | 0 | 0 |
Array BioPharma Inc. | COM | 04269X105 | 22,347 | 3,310,666 | SH | | SOLE | | 3,310,666 | 0 | 0 |
Arrowhead Pharmaceuticals, Inc. | COM | 04280A100 | 13,649 | 1,856,967 | SH | | SOLE | | 1,856,967 | 0 | 0 |
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 14,985 | 745,521 | SH | | SOLE | | 745,521 | 0 | 0 |
Assembly Biosciences, Inc. | COM | 045396108 | 1,803 | 250,000 | SH | | SOLE | | 250,000 | 0 | 0 |
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 58,930 | 1,912,680 | SH | | SOLE | | 24,864,840 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | COM | 079481107 | 96,826 | 4,865,647 | SH | | SOLE | | 4,865,647 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 48,351 | 10,963,944 | SH | | SOLE | | 10,963,944 | 0 | 0 |
BioDelivery Sciences International, Inc. | COM | 09060J106 | 567 | 210,021 | SH | | SOLE | | 210,021 | 0 | 0 |
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 444,696 | 4,806,483 | SH | | SOLE | | 4,806,483 | 0 | 0 |
BioTime, Inc. | *W EXP 10/1/201 | 09066L162 | 17 | 20,084 | SH | | SOLE | | 20,084 | 0 | 0 |
bluebird bio, Inc. | COM | 09609G100 | 19,923 | 293,943 | SH | | SOLE | | 293,943 | 0 | 0 |
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 5,561 | 5,102,153 | SH | | SOLE | | 5,102,153 | 0 | 0 |
Cellectis S.A. | SPONSORED ADS | 15117K103 | 1,204 | 50,000 | SH | | SOLE | | 50,000 | 0 | 0 |
Cerus Corporation | COM | 157085101 | 81,061 | 13,053,275 | SH | | SOLE | | 13,053,275 | 0 | 0 |
ChemoCentryx, Inc. | COM | 16383L106 | 296 | 49,064 | SH | | SOLE | | 49,064 | 0 | 0 |
Chimerix, Inc. | COM | 16934W106 | 638 | 115,216 | SH | | SOLE | | 115,216 | 0 | 0 |
CoLucid Pharmaceuticals, Inc. | COM | 19716T101 | 1,156 | 30,310 | SH | | SOLE | | 30,310 | 0 | 0 |
Concert Pharmaceuticals, Inc. | COM | 206022105 | 3,205 | 316,976 | SH | | SOLE | | 316,976 | 0 | 0 |
ContraFect Corporation | COM | 212326102 | 10,034 | 4,045,876 | SH | | SOLE | | 4,045,876 | 0 | 0 |
Cyclacel Pharmaceuticals, Inc. | PFD CONV EX 6% | 23254L207 | 90 | 13,253 | SH | | SOLE | | 13,253 | 0 | 0 |
CytRx Corporation | COM PAR $.001 | 232828509 | 388 | 659,995 | SH | | SOLE | | 659,995 | 0 | 0 |
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 200,162 | 5,509,560 | SH | | SOLE | | 2,754,780 | 0 | 0 |
Derma Sciences, Inc. | COM PAR $.01 | 249827502 | 17,524 | 3,752,390 | SH | | SOLE | | 3,752,390 | 0 | 0 |
Dermira, Inc. | COM | 24983L104 | 11,040 | 326,428 | SH | | SOLE | | 326,428 | 0 | 0 |
Dimension Therapeutics, Inc. | COM | 25433V105 | 10,003 | 1,251,881 | SH | | SOLE | | 1,251,881 | 0 | 0 |
Dynavax Technologies Corporation | COM NEW | 268158201 | 787 | 75,000 | SH | | SOLE | | 75,000 | 0 | 0 |
Enanta Pharmaceuticals, Inc. | COM | 29251M106 | 2,005 | 75,357 | SH | | SOLE | | 75,357 | 0 | 0 |
Endocyte, Inc. | COM | 29269A102 | 2,685 | 868,983 | SH | | SOLE | | 868,983 | 0 | 0 |
Epizyme, Inc. | COM | 29428V104 | 2,288 | 232,481 | SH | | SOLE | | 232,481 | 0 | 0 |
Exelixis, Inc. | COM | 30161Q104 | 63,048 | 4,929,494 | SH | | SOLE | | 4,929,494 | 0 | 0 |
Five Prime Therapeutics, Inc. | COM | 33830X104 | 1,010 | 19,247 | SH | | SOLE | | 19,247 | 0 | 0 |
Foamix Pharmaceuticals Ltd. | SHS | M46135105 | 22,842 | 2,466,702 | SH | | SOLE | | 2,466,702 | 0 | 0 |
Foundation Medicine, Inc. | COM | 350465100 | 488 | 20,892 | SH | | SOLE | | 20,892 | 0 | 0 |
Fulgent Genetics, Inc. | COM | 359664109 | 1,153 | 125,000 | SH | | SOLE | | 125,000 | 0 | 0 |
Galapagos NV | SPONSORED ADR | 36315X101 | 16,805 | 259,894 | SH | | SOLE | | 259,894 | 0 | 0 |
Genomic Health, Inc. | COM | 37244C101 | 398,237 | 13,770,302 | SH | | SOLE | | 13,770,302 | 0 | 0 |
GlycoMimetics, Inc. | COM | 38000Q102 | 2,726 | 381,235 | SH | | SOLE | | 381,235 | 0 | 0 |
Halozyme Therapeutics, Inc. | COM | 40637H109 | 20,911 | 1,731,057 | SH | | SOLE | | 1,731,057 | 0 | 0 |
Heron Therapeutics, Inc. | COM | 427746102 | 49,230 | 2,857,250 | SH | | SOLE | | 2,857,250 | 0 | 0 |
Idera Pharmaceuticals, Inc. | COM NEW | 45168K306 | 17,956 | 7,014,015 | SH | | SOLE | | 7,014,015 | 0 | 0 |
Ignyta, Inc. | COM | 451731103 | 3,592 | 571,000 | SH | | SOLE | | 571,000 | 0 | 0 |
Immune Design Corp. | COM | 45252L103 | 1,129 | 148,937 | SH | | SOLE | | 148,937 | 0 | 0 |
ImmunoGen, Inc. | COM | 45253H101 | 8,081 | 3,015,353 | SH | | SOLE | | 3,015,353 | 0 | 0 |
Incyte Corporation | COM | 45337C102 | 2,215,711 | 23,498,898 | SH | | SOLE | | 23,498,898 | 0 | 0 |
Infinity Pharmaceuticals, Inc. | COM | 45665G303 | 905 | 580,400 | SH | | SOLE | | 580,400 | 0 | 0 |
Insmed Incorporated | COM PAR $.01 | 457669307 | 5,808 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Intellia Therapeutics, Inc. | COM | 45826J105 | 18,077 | 1,062,120 | SH | | SOLE | | 1,062,120 | 0 | 0 |
Intra-Cellular Therapies, Inc. | COM | 46116X101 | 9,284 | 609,166 | SH | | SOLE | | 609,166 | 0 | 0 |
Invitae Corporation | COM | 46185L103 | 57,422 | 6,554,967 | SH | | SOLE | | 6,554,967 | 0 | 0 |
InVivo Therapeutics Holdings Corp. | COM NEW | 46186M209 | 2,720 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | COM | 462222100 | 2,094 | 57,140 | SH | | SOLE | | 57,140 | 0 | 0 |
Juno Therapeutics, Inc. | COM | 48205A109 | 2,401 | 80,000 | SH | | SOLE | | 80,000 | 0 | 0 |
Karyopharm Therapeutics Inc. | COM | 48576U106 | 2,111 | 216,990 | SH | | SOLE | | 216,990 | 0 | 0 |
La Jolla Pharmaceutical Company | COM PAR $.0001 2 | 503459604 | 327 | 13,746 | SH | | SOLE | | 13,746 | 0 | 0 |
Ligand Pharmaceuticals Incorporated | COM NEW | 53220K504 | 7,490 | 73,386 | SH | | SOLE | | 73,386 | 0 | 0 |
Loxo Oncology, Inc. | COM | 548862101 | 3,606 | 137,735 | SH | | SOLE | | 137,735 | 0 | 0 |
MacroGenics, Inc. | COM | 556099109 | 10,878 | 363,676 | SH | | SOLE | | 363,676 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 732 | 57,762 | SH | | SOLE | | 57,762 | 0 | 0 |
Mast Therapeutics, Inc. | COM | 576314108 | 944 | 8,584,051 | SH | | SOLE | | 8,584,051 | 0 | 0 |
Medgenics, Inc. | COM NEW | 58436Q203 | 4,905 | 880,539 | SH | | SOLE | | 880,539 | 0 | 0 |
MediWound Ltd. | ORD SHS | M68830104 | 1,740 | 226,000 | SH | | SOLE | | 226,000 | 0 | 0 |
Merus N.V. | COM | N5749R100 | 19,430 | 1,160,014 | SH | | SOLE | | 1,160,014 | 0 | 0 |
Minerva Neurosciences, Inc. | COM | 603380106 | 3,653 | 258,805 | SH | | SOLE | | 258,805 | 0 | 0 |
Mirati Therapeutics, Inc. | COM | 60468T105 | 14,999 | 2,269,198 | SH | | SOLE | | 2,269,198 | 0 | 0 |
MyoKardia, Inc. | COM | 62857M105 | 1,634 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Nabriva Therapeutics AG | SPONSORED ADR | 62957M104 | 2,468 | 350,000 | SH | | SOLE | | 35,000 | 0 | 0 |
Natera, Inc. | COM | 632307104 | 5,000 | 450,000 | SH | | SOLE | | 450,000 | 0 | 0 |
Neurocrine Biosciences, Inc. | COM | 64125C109 | 45,344 | 895,422 | SH | | SOLE | | 895,422 | 0 | 0 |
NeuroDerm Ltd. | ORD SHS | M74231107 | 5,639 | 305,000 | SH | | SOLE | | 305,000 | 0 | 0 |
Ophthotech Corporation | COM | 683745103 | 1,644 | 35,649 | SH | | SOLE | | 35,649 | 0 | 0 |
Osiris Therapeutics, Inc. | COM | 68827R108 | 2,476 | 499,193 | SH | | SOLE | | 499,193 | 0 | 0 |
Palatin Technologies, Inc. | COM PAR $.01 | 696077403 | 1,289 | 2,050,000 | SH | | SOLE | | 2,050,000 | 0 | 0 |
Progenics Pharmaceuticals, Inc. | COM | 743187106 | 23,110 | 3,650,808 | SH | | SOLE | | 3,650,808 | 0 | 0 |
ProNAi Therapeutics, Inc. | COM | 74346L101 | 364 | 200,000 | SH | | SOLE | | 200,000 | 0 | 0 |
ProQR Therapeutics N.V. | SHS EURO | N71542109 | 5,739 | 860,464 | SH | | SOLE | | 860,464 | 0 | 0 |
Proteon Therapeutics, Inc. | COM | 74371L109 | 2,786 | 298,591 | SH | | SOLE | | 298,591 | 0 | 0 |
Ritter Pharmaceuticals, Inc. | COM | 767836109 | 672 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Sage Therapeutics, Inc. | COM | 78667J108 | 9,594 | 208,328 | SH | | SOLE | | 208,328 | 0 | 0 |
Sangamo BioSciences, Inc. | COM | 800677106 | 18,779 | 4,055,876 | SH | | SOLE | | 4,055,876 | 0 | 0 |
SCYNEXIS, Inc. | COM | 811292101 | 1,810 | 467,600 | SH | | SOLE | | 467,600 | 0 | 0 |
Seattle Genetics, Inc. | COM | 812578102 | 2,381,857 | 44,100,294 | SH | | SOLE | | 44,100,294 | 0 | 0 |
Selecta Biosciences, Inc. | COM | 816212104 | 2,550 | 178,950 | SH | | SOLE | | 178,950 | 0 | 0 |
Seres Therapeutics, Inc. | COM | 81750R102 | 1,536 | 125,000 | SH | | SOLE | | 125,000 | 0 | 0 |
Spark Therapeutics, Inc. | COM | 84652J103 | 79,180 | 1,318,341 | SH | | SOLE | | 1,318,341 | 0 | 0 |
Stemline Therapeutics, Inc. | COM | 85858C107 | 3,612 | 333,497 | SH | | SOLE | | 333,497 | 0 | 0 |
Sunesis Pharmaceuticals, Inc. | COM PAR | 867328700 | 3,241 | 741,665 | SH | | SOLE | | 741,665 | 0 | 0 |
Syros Pharmaceuticals, Inc. | COM | 87184Q107 | 2,836 | 204,465 | SH | | SOLE | | 204,465 | 0 | 0 |
Tenax Therapeutics, Inc. | COM | 88032L100 | 972 | 420,000 | SH | | SOLE | | 420,000 | 0 | 0 |
TG Therapeutics, Inc. | COM | 88322Q108 | 15,511 | 2,003,991 | SH | | SOLE | | 2,003,991 | 0 | 0 |
Trevena, Inc. | COM | 89532E109 | 3,038 | 450,000 | SH | | SOLE | | 450,000 | 0 | 0 |
Trillium Therapeutics Inc. | COM NEW | 89620X506 | 6,120 | 413,697 | SH | | SOLE | | 413,697 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 7,094 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
uniQure N.V. | SHS | N90064101 | 1,760 | 230,000 | SH | | SOLE | | 230,000 | 0 | 0 |
Versartis, Inc. | COM | 92529L102 | 26,145 | 2,134,247 | SH | | SOLE | | 2,134,247 | 0 | 0 |
Vitae Pharmaceuticals, Inc. | COM | 92847N103 | 13,339 | 637,597 | SH | | SOLE | | 637,597 | 0 | 0 |
Windtree Therapeutics, Inc. | COM | 97382D105 | 653 | 254,973 | SH | | SOLE | | 254,973 | 0 | 0 |
Xencor, Inc. | COM | 98401F105 | 21,357 | 872,072 | SH | | SOLE | | 872,072 | 0 | 0 |
Zogenix, Inc. | COM NEW | 98978L204 | 11,430 | 1,000,000 | SH | | SOLE | | 1,000,000 | 0 | 0 |
Acorda Therapeutics, Inc. Notes 1.75% 6/15/2021 | NOTE 1.75% 6/15/2021 | 00484MAA4 | 62,830 | 77,083,000 | PRN | | SOLE | | 77,083,000 | 0 | 0 |
Aegerion Pharmaceuticals, Inc. Notes 2.0% 8/15/2019 | NOTE 2.0% 8/15/2019 | 00767EAB8 | 17,432 | 26,517,000 | PRN | | SOLE | | 26,517,000 | 0 | 0 |
Array BioPharma Inc. Notes 3.0% 6/1/2020 | NOTE 3.0% 6/1/2020 | 04269XAA3 | 3,561 | 3,000,000 | PRN | | SOLE | | 3,000,000 | 0 | 0 |
BioMarin Pharmaceutical Inc. Notes 1.875% 4/23/2017 | NOTE 1.875% 4/23/2017 | 09061GAD3 | 101,405 | 22,379,000 | PRN | | SOLE | | 22,379,000 | 0 | 0 |
BioMarin Pharmaceutical Inc. Notes 0.75% 10/15/2018 | NOTE 0.75% 10/15/2018 | 09061GAE1 | 14,630 | 12,228,000 | PRN | | SOLE | | 12,228,000 | 0 | 0 |
Clovis Oncology, Inc. 2.5% 9/15/2021 | NOTE 2.5% 9/15/2021 | 189464AB6 | 69,135 | 72,758,000 | PRN | | SOLE | | 72,758,000 | 0 | 0 |
Incyte Corporation Notes 0.375% 11/15/2018 144A | NOTE 0.375% 11/15/2018 | 45337CAK8 | 491,344 | 259,000,000 | PRN | | SOLE | | 259,000,000 | 0 | 0 |
Incyte Corporation Notes 1.25% 11/15/2020 144A | NOTE 1.25% 11/15/2020 | 45337CAL6 | 531,244 | 274,500,000 | PRN | | SOLE | | 274,500,000 | 0 | 0 |
Inotek Pharmaceuticals Corporation Notes 5.75% 8/1/2021 | NOTE 5.75% 8/1/2021 | 45780VAB8 | 6,708 | 5,000,000 | PRN | | SOLE | | 5,000,000 | 0 | 0 |
Protalix BioTherapeutics, Inc. Notes 4.5% 9/15/18 | NOTE 4.5% 9/15/2018 | 74365AAB7 | 2,294 | 3,423,000 | PRN | | SOLE | | 3,423,000 | 0 | 0 |